Enhancement of the bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with L-isoleucine as a competing agent.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D002936:Cinnarizine / Q000008:administration & dosage / Q000378:metabolism*; D003505:Cyclodextrins; D004285:Dogs; D005079:Excipients; D007532:Isoleucine / Q000378:metabolism; D008297:Male; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D005079:Excipients; D047392:beta-Cyclodextrins; D007532:Isoleucine; D002936:Cinnarizine; C031215:betadex